Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Igenica Inc.

Headquarters: Burlingame, CA, United States of America
Year Founded: 2009
Status: Private

BioCentury | Aug 10, 2022
Management Tracks

New CMOs at Arcus, Enanta

Plus Lamba becomes CFO at ImmPACT, and updates from Appia Bio and Quanterix
BioCentury | Jun 17, 2016
Company News

Management tracks

BioCentury | Dec 14, 2015
Company News

Igenica, AstraZeneca deal

BioCentury | Sep 4, 2015
Company News

Management tracks

BioCentury | Mar 9, 2015
Finance

Column's creations

How The Column Group's long-term strategy yielded three wins
BioCentury | Jun 16, 2014
Emerging Company Profile

NBE: Enzymatic ADCs

NBE's enzymatic ADCs carry multiple payloads, no mutagenesis required
BioCentury | Mar 24, 2014
Clinical News

IGN523: Phase I started

BioCentury | Feb 3, 2014
Finance

Appreciating in private

Why cancer antibody play Igenica stayed with private financing
BioCentury | Feb 3, 2014
Financial News

Igenica financial update

Items per page:
1 - 10 of 19